Standout Papers
Citation Impact
Citing Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Evidence-based guideline: Treatment of painful diabetic neuropathy [RETIRED]
2011
Impact of clinical pathways in surgery
2008
The Role of Innate and Adaptive Immunity in Parkinson's Disease
2013
A cluster randomized controlled trial of a clinical pathway for hospital treatment of heart failure: study design and population
2007
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
2010 Standout
Sex-Specific Differences in Hemodialysis Prevalence and Practices and the Male-to-Female Mortality Rate: The Dialysis Outcomes and Practice Patterns Study (DOPPS)
2014
Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics
2016
Patient Demographic and Socioeconomic Characteristics in the SEER-Medicare Database
2002
NeuPSIG guidelines on neuropathic pain assessment
2010 Standout
Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer
2010
Estrogen receptors and human disease
2006 Standout
The Validity of the Neuropathic Pain Scale for Assessing Diabetic Neuropathic Pain in a Clinical Trial
2005
Structural racism and health inequities in the USA: evidence and interventions
2017 Standout
Clinical pathway audit tools: a systematic review
2006
Comparison of Mortality Between Private For-Profit and Private Not-For-Profit Hemodialysis Centers
2002
Lipid nanoparticles for mRNA delivery
2021 Standout
What is “quality of evidence” and why is it important to clinicians?
2008 Standout
Pancreatic cancer
2020 Standout
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
2008 Standout
RNA delivery biomaterials for the treatment of genetic and rare diseases
2019
Initiation of a Critical Pathway for Pancreaticoduodenectomy at an Academic Institution—the First Step in Multidisciplinary Team Building
2007
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
2005 Standout
The Lifelong Effects of Early Childhood Adversity and Toxic Stress
2011 Standout
Mortality Risk by Hemodialyzer Reuse Practice and Dialyzer Membrane Characteristics: Results From the USRDS Dialysis Morbidity and Mortality Study
2001
A new definition of neuropathic pain
2011 Standout
Spinal cord stimulation versus conventional medical management for neuropathic pain: A multicentre randomised controlled trial in patients with failed back surgery syndrome
2007 Standout
Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival
2013 Standout
Racial and Ethnic Disparities in the Health and Health Care of Children
2010
Nonsimultaneous Chains and Dominos in Kidney- Paired Donation—Revisited
2011 StandoutNobel
Effective Doses in Radiology and Diagnostic Nuclear Medicine: A Catalog
2008 Standout
The Effect of Patients' Preferences on Racial Differences in Access to Renal Transplantation
1999
Qualitative Data Analysis for Health Services Research: Developing Taxonomy, Themes, and Theory
2007 Standout
Revisiting Survival Differences by Race and Ethnicity among Hemodialysis Patients
2006
LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation
2021 StandoutNobel
Chronic kidney disease
2011 Standout
Pharmacologic management of neuropathic pain: Evidence-based recommendations
2007 Standout
Serratia liquefaciensBloodstream Infections from Contamination of Epoetin Alfa at a Hemodialysis Center
2001
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
2016 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Primary Care Physicians Who Treat Blacks and Whites
2004 Standout
Participation in Cancer Clinical Trials
2004 Standout
EFNS guidelines on pharmacological treatment of neuropathic pain
2006
To have and have not: Health and health care disparities in chronic kidney disease
2003
Implicit and Explicit Anti-Fat Bias among a Large Sample of Medical Doctors by BMI, Race/Ethnicity and Gender
2012 Standout
Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment
2010 Standout
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Drug delivery systems for RNA therapeutics
2022
Diabetic neuropathy: clinical manifestations and current treatments
2012
Deviation-Based Cost Modeling: A Novel Model to Evaluate the Clinical and Economic Impact of Clinical Pathways
2007
Chronic kidney disease: global dimension and perspectives
2013 Standout
Placebo Response Changes Depending on the Neuropathic Pain Syndrome: Results of a Systematic Review and Meta-Analysis
2012
Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis
2002 Standout
Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug
2020
Physicians' Attitudes Toward Homosexuality and HIV
2007
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Evidence‐based guideline: Treatment of painful diabetic neuropathy—report of the american association of neuromuscular and electrodiagnostic medicine, the american academy of neurology, and the american academy of physical medicine & rehabilitation
2011
Research on the Provider Contribution to Race/Ethnicity Disparities in Medical Care
2002
The Cross‐Dehydrogenative Coupling of CH Bonds: A Versatile Strategy for CC Bond Formations
2013 Standout
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
2015 Standout
Possible Role of Ovarian Epithelial Inflammation in Ovarian Cancer
1999
Lesbian, Gay, Bisexual, and Transgender–Related Content in Undergraduate Medical Education
2011 Standout
Zonisamide in the Treatment of Painful Diabetic Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
2005
The evidence for pharmacological treatment of neuropathic pain
2010
Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence
2011 Standout
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
Glyceryl trinitrate spray in the management of painful diabetic neuropathy: A randomized double blind placebo controlled cross-over study
2007
Assessment of Racial Disparities in Chronic Kidney Disease Stage 3 and 4 Care in the Department of Defense Health System
2008
Algorithm for neuropathic pain treatment: An evidence based proposal
2005
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Painful Diabetic Polyneuropathy
2011
Chronic Kidney Disease
2016 Standout
Chronic Progressive Calcineurin Nephrotoxicity: An Overstated Concept
2011
Inflammation Lesions in Kidney Transplant Biopsies: Association with Survival Is Due to the Underlying Diseases
2011
Ethnic Disparities in Diabetic Complications in an Insured Population
2002 Standout
NF-κB: linking inflammation and immunity to cancer development and progression
2005 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells.
2001
Impacto de una vía clínica para pacientes intervenidos con resección transuretral en próstata y vejiga
2006
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
The Association of Poverty With the Prevalence of Albuminuria: Data From the Third National Health and Nutrition Examination Survey (NHANES III)
2006
Diagnostic radiology in Norway trends in examination frequency and collective effective dose
2007
Sexual and Gender Minority Health: What We Know and What Needs to Be Done
2008 Standout
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Lipid Delivery Systems for Nucleic-Acid-Based-Drugs: From Production to Clinical Applications
2019
Clinical Pathways in General Surgery
2007
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Pharmacologic Interventions for Painful Diabetic Neuropathy
2014
Scalable mRNA and siRNA Lipid Nanoparticle Production Using a Parallelized Microfluidic Device
2021 StandoutNobel
Regional Assessment of Atrazine Exposure and Incidence of Breast and Ovarian Cancers in Kentucky
2002
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Evidence-Based Surgical Care and the Evolution of Fast-Track Surgery
2008 Standout
The AJT Report: News and issues that affect organ and tissue transplantation
2012
Mechanistic Studies on the Catalytic Asymmetric Mannich-Type Reaction with Dihydroisoquinolines and Development of Oxidative Mannich-Type Reactions Starting from Tetrahydroisoquinolines
2008
Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs
2010 Standout
Works of Pushkal Garg being referenced
Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis
2019
Correction to: Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)
2020
Income-based disparities in outcomes for patients with chronic kidney disease
2001
Impact of Gender on Access to the Renal Transplant Waiting List for Pediatric and Adult Patients
2000
Reducing racial disparities in transplant activation:Whom should we target?
2001
Affinity of 2-(tetrahydroisoquinolin-2-ylmethyl)- and 2-(isoindolin-2-ylmethyl)imidazolines for .alpha.-adrenoceptors. Differential affinity of imidazolines for the [3H]idazoxan-labeled .alpha.2-adrenoceptor vs the [3H]yohimbine-labeled site
1990
Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysis
1998
Belatacept-Based Regimens Versus a Cyclosporine A-Based Regimen in Kidney Transplant Recipients: 2-Year Results From the BENEFIT and BENEFIT-EXT Studies
2010
Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study
2003
Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)
2020
A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)
2010 Standout
Understanding Individual and Small Area Variation in the Underuse of Coronary Angiography Following Acute Myocardial Infarction
2002
Impact of Underuse, Overuse, and Discretionary Use on Geographic Variation in the Use of Coronary Angiography After Acute Myocardial Infarction
2001
Divalproex sodium in the management of post-herpetic neuralgia: a randomized double-blind placebo-controlled study
2004
Are Critical Pathways Effective for Reducing Postoperative Length of Stay?
2003
Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT‐EXT Study)
2010
Effect of the Ownership of Dialysis Facilities on Patients' Survival and Referral for Transplantation
1999
2003
Critical Pathway Effectiveness: Assessing the Impact of Patient, Hospital Care, and Pathway Characteristics Using Qualitative Comparative Analysis
2005
Critical pathway effectiveness: assessing the impact of patient, hospital care, and pathway characteristics using qualitative comparative analysis.
2005
Single‐Dose Pharmacokinetics and Pharmacodynamics of Transthyretin Targeting N‐acetylgalactosamine–Small Interfering Ribonucleic Acid Conjugate, Vutrisiran, in Healthy Subjects
2020
A Subcutaneously Administered Investigational RNAi Therapeutic (ALN-CC5) Targeting Complement C5 for Treatment of PNH and Complement-Mediated Diseases: Interim Phase 1 Study Results
2015
Racial Differences in Access to the Kidney Transplant Waiting List for Children and Adolescents With End-Stage Renal Disease
2000